Abstract
Until recently the role of MRI in the evaluation of bowel diseases has been limited to the assessment of ano-rectal abnormalities, as long acquisition times resulted in motion artifacts from breathing and intestinal peristalsis. Recent technological advances have greatly improved the quality of abdominal MRI so as to allow it to be used for the evaluation of the bowel wall in inflammatory bowel disease (IBD). Rapid acquisition sequences have resulted in a significant reduction in motion artifacts and can now provide excellent dynamic contrast-enhanced studies of the bowel wall. Spatial resolution can be increased by using phased array coils. The contrast of the image can be modulated and improved by suppressing the signal of fat in either T1 or T2 weighted images, or through the administration of positive or negative oral contrast agents, both of which are now commercially available (Giovagnoni et al. 2002). Three-dimensional post-processing can be used in MRI as well as CT, to produce maximum intensity projection (MIP) or volume rendered images that are comparable to barium contrast studies and to conventional endoscopic views, respectively (Wildersmuth and Debatin 1999) and in the future, real time MRI (fluoro-MRI) will become available.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Debatin JF, Patak MA (1999) MRI of the small and large bowel. Eur Radiol 9:1523–1534
Ernst O, Asselah T, Cablan X et al (1998) Breath-hold fast spin-echo MR imaging of Crohn’s disease. AJR 170:127–128
Farmer RG, Hawk WA, Turnbull RB (1975) Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology 68:627–635
Giovagnoni A, Fabbri F, Maccioni F (2002) Oral contrast agent in MRI of the gastrointestinal tract. Abdom Imaging 27: 367–375
Goldberg HI, Caruthers SB Jr, Nelson JA et al (1979) Radiographic findings of the National Cooperative Crohn’s Disease Study. Gastroenterology 77:925–933
Gore RM (1994) Cross sectional imaging of the colon. In: Gore RM, Levine MS, Laufer I (eds) Textbook of gastrointestinal radiology. Saunders, Philadelphia, pp 1052–1063
Gore RM, Balthazar EJ, Ghahremani GG et al (1996) CT features of ulcerative colitis and Crohn’s disease. AJR 167:3–15
Gore RM, Ghahremani GG, Miller FH (1997) Inflammatory bowel disease: radiologic diagnosis. In: Balfe DM, Levine MS (eds) Syllabus of Radiological Society of North America Categorical Course in Gastrointestinal Radiology. RSNA, pp 95–110
Gourtsoyiannis N, Papanikolaou N, Grammatikakis J et al (2001) MR enteroclysis protocol optimization: comparison between 3D FLASH with fat saturation after intravenous gadolinium injection and true FISP sequences. Eur Radiol 11:908–913
Hann PF, Stark DD, Lewis JM et al (1990) First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 175:695–700
Jewell DP (1993) Ulcerative colitis. In: Sleisenger MH, Foerdtran JS (eds) Gastrointestinal disease, 4th edn. Saunders, Philadelphia, pp 1305–1330
Jones B, Fishman EK, Hamilton SR et al (1986) Submucosal accumulation of fat in inflammatory bowel disease: CT/pathologic correlation J Comput Assist Tomogr 10: 759–763
Kangas E, Matikainen M, Mattila J (1994) Is “indeterminate colitis” Crohn’s disease in the long-term follow-up? Int Surg 79:120–125
Kettritz U, Isaaks K, Warshauer DM et al (1995) Crohn disease. Pilot study comparing MRI of the abdomen with clinical evaluation. J Clin Gastroenterol 21:249–253
Klein VHM, Wein B, Adam G et al (1995) Computed tomography of Crohn’s disease and ulcerative colitis. Fortschr Roentgenstr 163:9–15
Koh DM, Miao Y, Chinn RJ et al (2001) MR imaging evaluation of the activity of Crohn’s disease. AJR 117:1325–1332
Laghi A, Carbone I, Catalano C et al (2001) Polyethyline glycol solution as an oral contrast agent for MR Imaging of the small bowel. Am J Roentgenol 177:1333–1334
Lasner BH (2000) Clinical Features, course, laboratory findings, and complications in ulcerative colitis. In: Kirsner JB (ed) Inflammatory bowel disease, 5th edn. Saunders, Philadelphia, pp 305–314
Lee JK, Semelka RC (1998) MR imaging of the small bowel using the HASTE sequence. AJR 170:1457–1463
Lomas DJ (1999) The potential of MR for small bowel imaging. Imaging 11:161–169
Low RN, Sebrechts CP, Politoske DA et al (2002) Crohn disease with endoscopic correlation: single shot fast spin echo and gadolinium enhanced fat-suppressed spoiled gradient-echo MR imaging. Radiology 222:652–660
Maccioni F (2002) Current status of gastrointestinal MRI. Abdom Imaging 27:384–393
Maccioni F, Viscido A, Broglia L et al (2000) Evaluation of Crohn disease activity with MRI. Abdom Imaging 25: 219–228
Maccioni F, Viscido A, Marini M et al (2002) MRI evaluation of Crohn’s disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents. Abdom Imaging 27:384–393
Madsen SM, Thomsen HS, Munkholm P et al (1998) Active Crohn’s disease and ulcerative colitis evaluated by low-field magnetic resonance imaging. Scand J Gastroenterol 33:1193–1200
Madsen SM, Thomsen HS, Schlichting P et al (1999) Evaluation of treatment response in active Crohn’s disease by low-field magnetic resonance imaging. Abdom Imaging 24:232–239
Miner PB (2000) Clinical features, course, laboratory findings, and complications in ulcerative colitis. In: Kirsner JB (ed) Inflammatory bowel disease, 5th edn. Saunders, Philadelphia, pp 299–304
Muldowney SM, Balfe DM, Hammerman A et al (1995) “Acute” fat deposition in bowel wall submucosa: CT appearance. J Comput Assist Tomogr 19:390–393
Philpotts LE, Heiken JP, Westcott MA et al (1994) Colitis: use of CT findings in differential diagnosis. Radiology 190:445–449
Price AB (1978) Overlap in the spectrum of non-specific inflammatory bowel disease “colitis indeterminate”. J Clin Pathol 31:567–574
Rieber A, Aschoff A, Nussle K et al (2000) MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol 10:1377–1382
Riddell RH (1998) Pathology of idiopathic inflammatory bowel disease. In: Kirsner JB (ed) Inflammatory bowel disease, 5th edn. Saunders, Philadelphia, pp 427–447
Rioux M, Gagnon J (1997) Imaging modalities in the puzzling world of inflammatory bowel disease. Abdom Imaging 22: 173–174
Semelka RC, Shoenut RP, Silverman R et al (1991) Bowel disease: prospective comparison of CT and 1.5 T pre-and post-contrast MR imaging with Tl-weighted fat-suppressed and breath-hold FLASH sequences. J Magn Res Imag 1:625–632
Shoenut JP, Semelka RC, Silverman R et al (1993) Magnetic resonance imaging in inflammatory bowel disease. J Clin Gastroenterol 17:73–78
Shoenut JP, Semelka RC, Magro CM et al (1994) Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol 19:31–35
Truelove SC, Pena AS (1976) Course and prognosis of Crohn’s disease. Gut 17:192–198
Wildersmuth S, Debatin JF (1999) Virtual endoscopy in abdominal MR imaging. Magn Reson Imaging Clin North Am 7:349–364
Wills JS, Lobis IF, Denstman FJ (1997) Crohn disease: state of the art. Radiology 202:597–610
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Maccioni, F. (2004). MRI of Colitis. In: Chapman, A.H. (eds) Radiology and Imaging of the Colon. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18834-3_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-18834-3_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62314-1
Online ISBN: 978-3-642-18834-3
eBook Packages: Springer Book Archive